24 related articles for article (PubMed ID: 32521927)
1. TIP30 directly binds p53 tumor suppressor protein in vitro.
Lee SH; Ju SK; Lee TY; Huh SH; Han KH
Mol Cells; 2012 Nov; 34(5):495-500. PubMed ID: 23178973
[TBL] [Abstract][Full Text] [Related]
2. Percutaneous microwave ablation and transcatheter arterial chemoembolization for serum tumor markers and prognostics of middle-late primary hepatic carcinoma.
Lin ZP; Huang DB; Zou XG; Chen Y; Li XQ; Zhang J
World J Gastrointest Surg; 2023 Dec; 15(12):2783-2791. PubMed ID: 38222024
[TBL] [Abstract][Full Text] [Related]
3. HTATIP2 Overexpression was Associated With a Good Prognosis in Gastric Cancer.
Park SY; Park JH; Yang JW; Jung EJ; Ju YT; Jeong CY; Kim JY; Park T; Park M; Lee YJ; Jeong SH
Technol Cancer Res Treat; 2024; 23():15330338231187254. PubMed ID: 38303513
[No Abstract] [Full Text] [Related]
4. Efficacy and safety of Agatroban in improving the prognosis of ischemic stroke patients.
Peng Z
Am J Transl Res; 2023; 15(9):5699-5706. PubMed ID: 37854211
[TBL] [Abstract][Full Text] [Related]
5. The potential role of human HIV-1 TAT-Interactive Protein 2 levels in the pathogenesis of contact dermatitis.
Metin MS; Bilen H; Elmas ÖF; Akdeniz N
Turk J Med Sci; 2021 Dec; 51(6):3017-3021. PubMed ID: 34688245
[TBL] [Abstract][Full Text] [Related]
6. 3D conformal radiotherapy combined with transcatheter arterial chemoembolization for hepatocellular carcinoma.
Zou LQ; Zhang BL; Chang Q; Zhu FP; Li YY; Wei YQ; Guan YS
World J Gastroenterol; 2014 Dec; 20(45):17227-34. PubMed ID: 25493039
[TBL] [Abstract][Full Text] [Related]
7. TIP30: A Novel Tumor-Suppressor Gene.
Yu X; Li Z; Wu WK
Oncol Res; 2014; 22(5-6):339-48. PubMed ID: 26629947
[TBL] [Abstract][Full Text] [Related]
8. The effects of interventional therapy on serum HTATIP2/TIP30, B7-H4 and short-term curative effect in primary hepatocellular carcinoma.
Zheng ZJ; Fu J; Zhi F; Liu WJ; Guo YJ; Zhu DD; Mo JG
Eur Rev Med Pharmacol Sci; 2018 Oct; 22(20):6778-6783. PubMed ID: 30402840
[TBL] [Abstract][Full Text] [Related]
9. Analysis on efficacy and safety of TACE in combination with RFA and MWA in the treatment of middle and large primary hepatic carcinoma.
Yuan P; Zhang Z; Kuai J
J BUON; 2019; 24(1):163-170. PubMed ID: 30941966
[TBL] [Abstract][Full Text] [Related]
10. Serum alpha-fetoprotein measurement in predicting clinical outcome related to autologous cytokine-induced killer cells in patients with hepatocellular carcinoma undergone minimally invasive therapy.
Pan CC; Huang ZL; Li W; Zhao M; Zhou QM; Xia JC; Wu PH
Chin J Cancer; 2010 Jun; 29(6):596-602. PubMed ID: 20507732
[TBL] [Abstract][Full Text] [Related]
11. A low serum Tat-interacting protein 30 level is a diagnostic and prognostic biomarker for hepatocellular carcinoma.
Fan SS; Liao CS; Cao YD; Xiao PL; Deng T; Luo RC; Duan HX
Oncol Lett; 2017 Jun; 13(6):4208-4214. PubMed ID: 28599422
[TBL] [Abstract][Full Text] [Related]
12. Circulating B7-H4 in serum predicts prognosis in patients with hepatocellular carcinoma.
Zhang SA; Wu ZX; Zhang X; Zeng ZY; Li DL
Genet Mol Res; 2015 Oct; 14(4):13041-8. PubMed ID: 26505457
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of changes in AFP, HTATIP2/TIP30, B7-H4 and inflammatory cytokines after transcatheter arterial chemoembolization.
Zhang P; Chen Z; Chen L; Zang H; Zhu B; Shao W; Niu W
J BUON; 2020; 25(2):1206-1211. PubMed ID: 32521927
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
